Mitochondrial protein import dysfunction: mitochondrial disease, neurodegenerative disease and cancer

被引:64
作者
Palmer, Catherine S. [1 ,2 ]
Anderson, Alexander J. [1 ,2 ]
Stojanovski, Diana [1 ,2 ]
机构
[1] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia
关键词
Alzheimer' s disease; cancer; Huntington' mitochondria; neurodegeneration; Parkinson' protein import; TIM; TOM;
D O I
10.1002/1873-3468.14022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The majority of proteins localised to mitochondria are encoded by the nuclear genome, with approximately 1500 proteins imported into mammalian mitochondria. Dysfunction in this fundamental cellular process is linked to a variety of pathologies including neuropathies, cardiovascular disorders, myopathies, neurodegenerative diseases and cancer, demonstrating the importance of mitochondrial protein import machinery for cellular function. Correct import of proteins into mitochondria requires the co-ordinated activity of multimeric protein translocation and sorting machineries located in both the outer and inner mitochondrial membranes, directing the imported proteins to the destined mitochondrial compartment. This dynamic process maintains cellular homeostasis, and its dysregulation significantly affects cellular signalling pathways and metabolism. This review summarises current knowledge of the mammalian mitochondrial import machinery and the pathological consequences of mutation of its components. In addition, we will discuss the role of mitochondrial import in cancer, and our current understanding of the role of mitochondrial import in neurodegenerative diseases including Alzheimer's disease, Huntington's disease and Parkinson's disease.
引用
收藏
页码:1107 / 1131
页数:25
相关论文
共 50 条
  • [41] Mitochondrial dysfunction in Parkinson's disease
    Hu, Qingsong
    Wang, Guanghui
    TRANSLATIONAL NEURODEGENERATION, 2016, 5
  • [42] Mitochondrial dysfunction in Parkinson's disease
    Hattori, Nobutaka
    Sato, Shigeto
    JOURNAL OF NEURAL TRANSMISSION, 2024, 131 (12) : 1415 - 1428
  • [43] Mitochondrial dysfunction in Parkinson's disease
    Winklhofer, Konstanze F.
    Haass, Christian
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01): : 29 - 44
  • [44] Mitochondrial dysfunction in Parkinson’s disease
    Qingsong Hu
    Guanghui Wang
    Translational Neurodegeneration, 5
  • [45] Mitochondrial Dysfunction and Kidney Stone Disease
    Chaiyarit, Sakdithep
    Thongboonkerd, Visith
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [46] Modulation of mitochondrial dysfunction for treatment of disease
    Webb, Michael
    Sideris, Dionisia P.
    Biddle, Margaret
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (11) : 1270 - 1277
  • [47] Mitochondrial dysfunction in Parkinson's disease
    Buneeva O.A.
    Medvedev A.E.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2011, 5 (4) : 313 - 336
  • [48] Metabolomics and mitochondrial dysfunction in cardiometabolic disease
    Shastry, Abhishek
    Dunham-Snary, Kimberly
    LIFE SCIENCES, 2023, 333
  • [49] Mitochondrial dysfunction and neuroinflammation in Parkinson disease
    WANG Yu-xi
    ZHANG Si-ran
    ZHOU Jun-yu
    ZHAO Jian-bo
    LI Cheng-tan
    ZHANG Li-hui
    中国药理学与毒理学杂志, 2019, (10) : 850 - 851
  • [50] Mitochondrial assembly: protein import
    Hood, DA
    Joseph, AM
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2004, 63 (02) : 293 - 300